Medigen COVID-19 vaccine receives EUA in Paraguay : comparem

Taipei, Feb. 14 (CNA) A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.

Related Keywords

Paraguay , Taipei , T Ai Pei , Taiwan , United States , South Korea , Han , American , Luke Sabatier , Astrazeneca , World Health Organization Phase , Medigen Vaccine Biologics Corp , Medigen Vaccine Biologics , South American , World Health Organization , Trial Vaccines , Han Ting ,